Navigation Links
New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
Date:4/19/2012

as smoking and excess weight have also been linked to the condition.

Some patients find methotrexate and other older medications difficult to tolerate and stop using them because of side effects such as nausea, hair thinning or liver problems, Gelfand explained.

In the research, three biologics and phototherapy were compared with methotrexate, an immunosuppressant also used in cancer treatment.

The study included 713 patients, almost equally divided among men and women, who were rated once for severity of the condition during a regularly scheduled appointment for treatment of psoriasis. Those who had a clear or almost clear skin assessment ranged from 24 percent for methotrexate users to between 34 and 48 percent for the three biologics studied. But, patients on methotrexate had about 3 percent of body surface affected, compared to 2 percent for the biologics, a small difference, said Gelfand.

Biologics can cost $10,000 to $20,000 a year, compared to a couple of thousand dollars for older drugs or phototherapy, said Gelfand.

Phototherapy was found to be about as effective as methotrexate, but is inconvenient because patients must see a doctor three times a week for three months to obtain the recommended dosage, and patients often don't comply with the regimen, Gelfand noted.

On self-assessments, patients found no significant differences among the treatments.

In contrast to the study, another expert on psoriasis said the newer drugs represent a real breakthrough.

Dr. Doris Day, a dermatologist at Lenox Hill Hospital in New York City, said biologics have worked better for many of her patients and have had fewer side effects. The drugs "give patients hope where there was no hope before," she said.

"In an otherwise healthy patient, if the patient has no infections, no TB [tuberculosis] and is not immuno-compromised, the risk with the biologics is low," she said.

Phototherapy poses a risk of skin cancer for
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Psoriasis Patients May Face Higher Heart Risk
2. Smoking Linked to Higher Rate of Psoriasis: Study
3. New Guidelines for Treating Psoriasis When Pregnant or Nursing
4. Psoriasis Treatments Convenience May Be Key for Patients
5. Does Psoriasis Thwart the Benefits of Good Cholesterol?
6. Psoriasis is associated with impaired HDL function, Penn study finds
7. Experimental Psoriasis Drug Bests Older Treatment
8. 1 in 4 With Psoriasis May Have Undiagnosed Arthritis
9. Kids With Psoriasis Get Inconsistent Care
10. Injectable Psoriasis Drugs May Not Hike Heart Risks: Study
11. Scientists Close in on Origins of Psoriasis, Eczema
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor ... a third doctoral program at its main campus in Reading: Doctor of Nursing Practice. ... designed to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... ... ... Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a free-standing emergency ... at US Highway 19 North and Highlands Boulevard, less than eight miles from the main ... is slated to begin in September 2015. , The new 24-bed facility will ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... NetDimensions ... , “The companies selected have the platforms required not only to effectively deliver, curate ... Taylor, President of Training Industry, Inc. , For six consecutive years, NetDimensions has ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... they have launched their new corporate website http://www.Z-Medica.com , to further support ... website that was launched last year. , “We launched a branded website ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Z-Medica® Launches New Corporate Website 2
... Heavy alcohol consumption, specifically three or more glasses of ... of death from pancreatic cancer, according to a report ... Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral cavity, ...
... , , , , ... AUDIO: Washington University,s Victoria Fraser, MD, talks about ... , , , , ... , , , , , , ...
... March 14 (HealthDay News) -- A lack of vitamin ... but levels of the vitamin don,t decrease as the ... insufficiency has been associated with a variety of clinical ... strength, mood and cognitive dysfunction, autoimmune disorders such as ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay News) -- Women ... fatty acids found in that meal choice -- have a ... suggests. This latest evidence of a protective link between ... found the same benefit. In this study, Harvard researchers performed ...
... March 14, 2011 -- Some physicians are prescribing opioids such ... a new study led by St. Michael,s Hospital and the ... opioid-related deaths occur among patients treated by physicians who frequently ... may not be doing so safely. "We found that ...
... technique called microdissection testicular sperm extraction (TESE) can effectively ... of adult male childhood cancer survivors who were previously ... result, many of the men were subsequently able to ... The findings offer a new option for many cancer ...
Cached Medicine News:Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Novel strategies target health care-associated infections 2Health News:Novel strategies target health care-associated infections 3Health News:Novel strategies target health care-associated infections 4Health News:Study: Lack of Vitamin D May Precede Onset of Parkinson's 2Health News:Eating Fish Might Protect Your Eyesight 2Health News:Eating Fish Might Protect Your Eyesight 3Health News:Painkiller prescribing varies dramatically among family physicians: study 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 3
(Date:8/27/2015)... NEWARK, N.J. , Aug. 27, 2015  Symbiomix ... Phase 3 clinical study, the second pivotal trial of ... the treatment of bacterial vaginosis (BV). Earlier this year ... for SYM-1219. Symbiomix expects to finish this second pivotal ... a New Drug Application (NDA) filing with the U.S. ...
(Date:8/27/2015)... -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN ) today announced that ... a corporate overview and business update at two investor conferences ... . , 22 nd Annual NewsMakers in ... Millennium Broadway Hotel. , Rodman & Renshaw Annual Global ... Regis Hotel. To access the live audio webcast ...
(Date:8/26/2015)... PUNE, India , August 27, 2015 ... market research reports reviewing the genotyping technology, ... as well as single nucleotide polymorphism (SNP) ... ReportsnReports.com. Complete report on genotyping ... spread across 200 pages, profiling 10 major ...
Breaking Medicine Technology:Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4SciClone To Present At Two Investor Conferences On September 10, 2015 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5
... The law firm of Childers, Schlueter & Smith, LLC of ... will be held during the week of July 26, 2010 .  The ... States District Court, Northern District of Georgia , Atlanta Division. , ... The lawsuit alleges that the drug makers and ...
... Inc. (NYSE Amex: MHH ) ("Mastech"), a national provider of Information Technology ... discuss the results of its second quarter ended June 30, 2010 . ... 9:00 a.m. Eastern Time and will be hosted by Mr. ... , , ...
Cached Medicine Technology:Childers, Schlueter & Smith, LLC Set for Reglan/metoclopramide Jury Trial Involving Woman's Development of Tardive Dyskinesia 2Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010 2
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
Inquire...
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
... A revolutionary urological imaging system ... that translate into improved patient ... 1k imaging technology physicians and ... see more anatomical detail and ...
Medicine Products: